✨
AI Summary
- Dr. Reddy's Chairman Satish Reddy discusses strategic use of generic Revlimid gains.
- He outlines India's needs for innovation: regulatory science, risk capital, and learnings from China.
- The company is building a diversified growth engine for India's innovation backbone.